DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Dimerix Limited

ASX:DXB Stock Report

Market Cap: AU$144.1m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Dimerix Management

Management criteria checks 2/4

Dimerix's CEO is Nina Webster, appointed in Aug 2018, has a tenure of 8.08 years. total yearly compensation is A$1.60M, comprised of 25.7% salary and 74.3% bonuses, including company stock and options. directly owns 0.089% of the company’s shares, worth A$128.92K. The average tenure of the management team and the board of directors is 2.3 years and 8.9 years respectively.

Key information

Nina Webster

Chief executive officer

AU$1.6m

Total compensation

CEO salary percentage25.70%
CEO tenure8.1yrs
CEO ownership0.09%
Management average tenure2.3yrs
Board average tenure8.9yrs

Recent management updates

Recent updates

Analysis Article • Dec 20

We're Interested To See How Dimerix (ASX:DXB) Uses Its Cash Hoard To Grow

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Dec 19

Is Dimerix (ASX:DXB) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Jul 05

We're A Little Worried About Dimerix's (ASX:DXB) Cash Burn Rate

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Analysis Article • Feb 17

Can Dimerix (ASX:DXB) Afford To Invest In Growth?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Analysis Article • Sep 16

We're A Little Worried About Dimerix's (ASX:DXB) Cash Burn Rate

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Analysis Article • Jun 02

We're Keeping An Eye On Dimerix's (ASX:DXB) Cash Burn Rate

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Sep 20

Most Shareholders Will Probably Agree With Dimerix Limited's (ASX:DXB) CEO Compensation

CEO Nina Webster has done a decent job of delivering relatively good performance at Dimerix Limited ( ASX:DXB...
Analysis Article • May 17

Is Dimerix (ASX:DXB) In A Good Position To Deliver On Growth Plans?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Analysis Article • Feb 01

Here's What We Think About Dimerix's (ASX:DXB) CEO Pay

This article will reflect on the compensation paid to Nina Webster who has served as CEO of Dimerix Limited ( ASX:DXB...

CEO Compensation Analysis

How has Nina Webster's remuneration changed compared to Dimerix's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026AU$2mAU$412k

-AU$30m

Mar 31 2026n/an/a

-AU$23m

Dec 31 2025n/an/a

-AU$16m

Sep 30 2025n/an/a

-AU$15m

Jun 30 2025AU$1mAU$400k

-AU$13m

Mar 31 2025n/an/a

-AU$18m

Dec 31 2024n/an/a

-AU$23m

Sep 30 2024n/an/a

-AU$20m

Jun 30 2024AU$759kAU$373k

-AU$17m

Mar 31 2024n/an/a

-AU$14m

Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$12m

Jun 30 2023AU$387kAU$350k

-AU$14m

Mar 31 2023n/an/a

-AU$14m

Dec 31 2022n/an/a

-AU$14m

Sep 30 2022n/an/a

-AU$12m

Jun 30 2022AU$517kAU$341k

-AU$10m

Mar 31 2022n/an/a

-AU$10m

Dec 31 2021n/an/a

-AU$9m

Sep 30 2021n/an/a

-AU$7m

Jun 30 2021AU$408kAU$334k

-AU$6m

Mar 31 2021n/an/a

-AU$6m

Dec 31 2020n/an/a

-AU$6m

Sep 30 2020n/an/a

-AU$5m

Jun 30 2020AU$539kAU$304k

-AU$4m

Compensation vs Market: Nina's total compensation ($USD1.14M) is above average for companies of similar size in the Australian market ($USD337.93K).

Compensation vs Earnings: Nina's compensation has increased whilst the company is unprofitable.


CEO

Nina Webster

8.1yrs
Tenure
AU$1,602,491
Compensation

Dr. Nina Webster, Ph D., BSc (Hons), M IP Law, MBA, has been Chief Executive Offer, Managing Director and Director of Dimerix Limited since August 27, 2018. Dr. Webster is Non-Executive Director of Imagion...


Leadership Team

NamePositionTenureCompensationOwnership
Nina Webster
CEO, MD & Director8.1yrsAU$1.60m0.089%
A$ 128.9k
Michael Tonroe
CFO & Company Secretaryless than a yearAU$322.58kno data
Robert Shepherd
Chief Operating Officer1.7yrsAU$466.82kno data
David Fuller
Chief Medical Officer2.9yrsAU$525.83kno data
Kevin Donald Pfleger
Chief Scientific Advisorno datano datano data
2.3yrs
Average Tenure

Experienced Management: DXB's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Nina Webster
CEO, MD & Director8.1yrsAU$1.60m0.089%
A$ 128.9k
Mark Diamond
Non-Executive Chairman2.8yrsAU$167.40kno data
Hugh Alsop
Independent Non-Executive Director9.3yrsAU$137.40kno data
Sonia Poli
Non Executive Director11.2yrsAU$137.40k0.11%
A$ 152.0k
Alessia Fornoni
Member of Medical Advisory Board8.9yrsno datano data
David Power
Member of Medical Advisory Board8.9yrsno datano data
Daniel Cattran
Member of Medical Advisory Board8.9yrsno datano data
Jonathan Hogan
Member of Medical Advisory Board8.9yrsno datano data
Clinton Snow
Non-Executive Director3.3yrsAU$137.40kno data
Laura Mariani
Member of ACTION3 Medical Advisory Board1.9yrsno datano data
8.9yrs
Average Tenure

Experienced Board: DXB's board of directors are considered experienced (8.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/17 09:05
End of Day Share Price 2026/09/17 00:00
Earnings2026/06/30
Annual Earnings2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dimerix Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide